Navigation Links
Mild Depression may guard aged women

Contravening a pile of evidence to the contrary, researchers reported, that mild depression may probably protect elderly women from premature death. Researchers at Duke University Medical Center in Durham, studied 3500 men and women ages 60 //and older who were interviewed every three years from 1989 to 1999. The interview subjects represented a random sample of the local population. Some participants were married, some widowed and some divorced. Some lived alone while others lived with their families.

During the interviews, researchers screened the subjects for depressive symptoms to determine if they met the criteria for mild depression, meaning symptoms such as occasional sleeping problems or feeling blue but not severe enough to warrant clinical intervention. The study participants' mortality rates also were followed over the years.

The study revealed that women exhibiting symptoms of mild depression died at a rate only 60 percent of that of women of the same age showing either no signs of depression or suffering more severe depression, according to the findings. Changing levels of depression and seemed to have no effects on the mortality of the study's male subjects.

Dr. Dan Blazer, professor of psychiatry, the author of this study, felt that there is a protective measure from mils depression. Conventional scientific thinking and current data indicate depression has multiple harmful effects on physical health, from heart disease to suppressing the immune system. Therefore it can speed up the road to dying. But Blazer said it is possible that mild depression, which typically does not require medical treatment, could be a coping mechanism for elderly women that might benefit them in the long run.

"It may be a sort of message to the body that something needs to be looked at, that you need to pay attention to it," Blazer said. No one is suggesting depression is good for you, he added, but milder symptoms may not be as ha
'"/>




Page: 1 2

Related medicine news :

1. Low Cholesterol Linked to Severe Depression and Violent Behavior in Men
2. Depression may cause delayed wound healing
3. Diabetes and Depression often go hand-in-hand
4. Depression and heart failure
5. Depression disturbs heart rate
6. Depression a possible danger in elderly
7. Depression linked to mortality
8. Depression increases heart attacks
9. More People Seeking Treatment for Depression
10. Depression elevates heart failure risk
11. Depression hurts the heart
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mild Depression may guard aged women

(Date:5/15/2008)...erapy given in conjunction with cancer vaccines ma...mproving the effectiveness of this promising type ...hers in the Duke Comprehensive Cancer Center. , ...hat suppress immune function and we speculated tha... in conjunction with vaccines, which work by boost...
(Date:5/15/2008)...y 15 /PRNewswire-FirstCall/ -- Digital Power,Corpo...y announced its,financial results for the first qu...ed revenue of $3,169,000 for the quarter ended,Mar...for the same quarter,last year. An operating loss ...rted, compared to an operating profit of $25,000 f...
(Date:5/15/2008)...PRNewswire/ -- JumpStart Inc., the Northeast Ohio,...the growth of innovative,early-stage businesses an...,$350,000 in CerviLenz(TM), Inc. The Cleveland-bas...Drug Administration cleared medical,device that al...th in,pregnant women, which has been established b...
(Date:5/15/2008)...Clinton Promise Comprehensive Healthcare Plans, Lo...e, Private Funding, KIRKLAND, Wash., May 15 /PRNe...oduce healthcare reform? "Probably," says Cameron ...nced long term care insurance,agencies, LTC Financ...Clinton,s, or perhaps McCain,s -- cover all health...
Breaking Medicine News(10 mins):Health News:Chemotherapy might help cancer vaccines work 2Health News:Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008 2Health News:Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008 3Health News:CerviLenz Receives JumpStart Investment 2Health News:CerviLenz Receives JumpStart Investment 3Health News:Don't Wait for the Election to Plan Your Long-Term Healthcare, Insurance Leader Advises 2
...ranean diet is a simple recipe for good health. Ha...0 Greeks found that those consuming the classic di...and vegetables and accompanied by a moderate amoun...id not."The closer you are to adhering to this die...
...mething, let it out and it might save you a headac...alize their anger more than those without headache..., 171 suffered from headaches. Investigators measu...perienced in daily life), internalized anger, host...
...bilt University shows cholesterol-lowering effects...ea. The study is the first placebo-controlled clin...perties of tea in humans. Studies of large populat...h benefits that include lower levels of LDL, or ba...
...occasional "bad day" are at increased risk of deve...w study . It is not uncommon for people over age 7...g in bed for at least half a day and/or cutting ba...e past month. Most physicians believe this is just...
Other Medicine News:Health News:Eat Like a Greek for Good Health 2
(Date:5/15/2008)... SAN FRANCISCO, May 15 /PRNewswire-FirstCall/ ...ed that data from an ongoing Phase 1-2 clinical,tr...3100, will be presented,in an oral presentation at...SCO) Annual Meeting in Chicago., Session title:...e Cancer Session date and time: Monday, June 2 at...
(Date:5/15/2008)... MELBOURNE, Australia, May 15 /PRNewswire-Firs...ed that the abstract for its upcoming oral,present...American Society,of Clinical Oncology (ASCO) will ...ttp://www.asco.org ) from 9pm on Thursday 15 May (...I evaluation of CYT997, a novel,cytotoxic and vasc...
(Date:5/15/2008)... BRIDGEWATER, N.J., May 15 /PRNewswire-FirstCa...) announced today that findings from the,landmark ...ential therapy,for the treatment of patients with ...he risk of cardiovascular hospitalizations or deat...% (p=0.00000002), meeting the study,primary endpoi...
(Date:5/15/2008)... BOSTON, May 15 /- CenterWatch, a...ed on market research about clinical,trials, finds...ltiple EDC,(electronic data capture) systems. More...urvey indicated that they had been trained on thre...icated that the effectiveness of,their EDC trainin...
Breaking Medicine Technology:Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2ARUP Laboratories CEO and Co Founder Announces Retirement 4658 1ARUP Laboratories CEO and Co Founder Announces Retirement 4658 2California Stem Cell Agency Exaggerated Its Role in Funding Key Research 1831 1California Stem Cell Agency Exaggerated Its Role in Funding Key Research 1831 2U of M researchers identify process that may help treat Parkinsons spinal cord injuries 17034 1U of M researchers identify process that may help treat Parkinsons spinal cord injuries 17034 2USP announces 2008 summer internship program participants 17031 1USP announces 2008 summer internship program participants 17031 2
...bstracts highlight VELCADE efficacy in broad range...RIDGE, Mass., June 19, 2007 /PRNewswire-FirstCall/...ed that data for,VELCADE, the market leading thera...ents with previously treated multiple myeloma,(MM)...yeloma,Workshop (IMW) in Kos, Greece, June 25-30, ...
...18, 2007 /PRNewswire-FirstCall/ -- Vical,Incorpora...nGes MG,Inc. reported positive results following ...s to complete a Phase 3 trial of an,angiogenesis p...logy. Based on the findings that the primary effic...tatistical,significance and that there were no maj...
Other Medicine Technology:Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum.
Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously.
...nesthesia and Respiratory Products, ,Westmed desi...ical devices for Anesthesia and Respiratory profes...products that enhance the clinician's ability to d...ention to the bottom line. , ,Our web site is des...
...he age of 3 can choose either the PARI LC PLUS®...applies to both:, ,Maximize aerosol output when t...n the patient exhales using two one-way valves. Ba... nebulizer. The result is a high percentage of par...
Medicine Products: